Cathepsin E, maspin, Plk1, and survivin are promising prognostic protein markers for progression in non-muscle invasive bladder cancer.
about
Prognostic role of survivin in bladder cancer: a systematic review and meta-analysisRisk prediction scores for recurrence and progression of non-muscle invasive bladder cancer: an international validation in primary tumours.External validation of a multiplex urinary protein panel for the detection of bladder cancer in a multicenter cohort.Prostaglandin receptors EP1-4 as a potential marker for clinical outcome in urothelial bladder cancer.Loss of MTUS1/ATIP expression is associated with adverse outcome in advanced bladder carcinomas: data from a retrospective study.The prognostic value and therapeutic target role of stathmin-1 in urinary bladder cancerHigh Expression of Cathepsin E in Tissues but Not Blood of Patients with Barrett's Esophagus and AdenocarcinomaClinical Significance of Substaging and HER2 Expression in Papillary Nonmuscle Invasive Urothelial Cancers of the Urinary Bladder.Growth differentiation factor-15: a p53- and demethylation-upregulating gene represses cell proliferation, invasion, and tumorigenesis in bladder carcinoma cellsConnexin 43 expression predicts poor progression-free survival in patients with non-muscle invasive urothelial bladder cancer.CD73 Predicts Favorable Prognosis in Patients with Nonmuscle-Invasive Urothelial Bladder Cancer.Cathepsin E Deficiency Ameliorates Graft-versus-Host Disease and Modifies Dendritic Cell Motility.High-risk non-muscle-invasive bladder cancer: update for a better identification and treatment.Prognostic value of survivin expression in breast cancer patients: a meta-analysis.Developing proteomic biomarkers for bladder cancer: towards clinical application.In vitro targeting of Polo-like kinase 1 in bladder carcinoma: comparative effects of four potent inhibitors.Inhibiting Polo-like kinase 1 causes growth reduction and apoptosis in pediatric acute lymphoblastic leukemia cellsBcCluster: A Bladder Cancer Database at the Molecular Level.Predictive value of molecular subtyping in NMIBC by RT-qPCR of ERBB2, ESR1, PGR and MKI67 from formalin fixed TUR biopsies.Proteomics analysis of bladder cancer invasion: Targeting EIF3D for therapeutic intervention.Corticotropin releasing hormone is correlated with tumorigenesis of gastric cancer.Maspin and it's evolving role in tumor progression in systemic malignancies.Improving outcome and prognosis prediction in non-muscle invasive bladder cancer using a gene expression score.Low expression of DAB2IP predicts an unfavorable prognosis in human bladder carcinoma.
P2860
Q27028122-178F352E-5225-4F45-A8DD-ACCE75AE7C07Q33721258-0EF7CE3A-0343-4AA4-AC00-76A6210C0434Q34135237-45DF6610-E4EA-46FF-BF50-8FF5A689B5F7Q34705013-3B601D19-A264-4921-86C9-84C45670ADCBQ35125879-E76CD42E-2A33-4FC7-BE18-C90889CACC95Q35214846-75A18564-94C0-4105-9063-9E6D02C3E6C8Q35690679-13147167-CA86-4154-B548-E00981B810FEQ35905097-CF16982C-3237-4772-B53D-761A142E0700Q35926034-9057901A-C6CD-4931-8DB3-3276D7F31F4AQ36150015-44DE97F8-9CAB-41DA-BF51-8C94638D999BQ36205304-D3464546-110B-48F3-AD8D-06DFECE181A7Q37672390-2F66CBB9-FF44-45E0-BFB9-0FD208F40160Q38052445-E911D64A-3B84-46E0-8F91-B32B0B318F8AQ38108262-C2F1B532-4B4E-47D2-9182-F6C5A963AC71Q38511509-A0F7F514-715A-455E-8632-19577CFBDAC7Q39136346-5B474933-A281-47A8-983B-345D05F87820Q39141522-7112B736-E0BD-4757-ADDE-1D7B6052D8F6Q39634042-8A60E4DA-2ABF-4CF5-B933-00C7F9E02EB4Q42366566-619BD693-24B3-4AC9-9CCA-940CACABADDBQ42378347-B4361192-1D15-4F0B-88F4-4FE4C3BCE0BCQ45776306-60B88D02-4C0D-41DC-95F0-8CAFDEDE11B6Q45906167-DC2A1D1C-4119-412A-B342-BFF4504F0DA2Q47126037-5F230B21-7F12-4415-BA3E-E44C52AA14E3Q47160507-B0766B45-972C-499E-8562-969A4D10AFAD
P2860
Cathepsin E, maspin, Plk1, and survivin are promising prognostic protein markers for progression in non-muscle invasive bladder cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Cathepsin E, maspin, Plk1, and ...... uscle invasive bladder cancer.
@en
Cathepsin E, maspin, Plk1, and ...... uscle invasive bladder cancer.
@nl
type
label
Cathepsin E, maspin, Plk1, and ...... uscle invasive bladder cancer.
@en
Cathepsin E, maspin, Plk1, and ...... uscle invasive bladder cancer.
@nl
prefLabel
Cathepsin E, maspin, Plk1, and ...... uscle invasive bladder cancer.
@en
Cathepsin E, maspin, Plk1, and ...... uscle invasive bladder cancer.
@nl
P2093
P50
P1476
Cathepsin E, maspin, Plk1, and ...... uscle invasive bladder cancer.
@en
P2093
Arndt Hartmann
Benedicte P Ulhøi
Francisco Mansilla
Joan Palou
Karsten Zieger
Marta Sanchez-Carbayo
Michael Borre
Miguel Alvarez-Múgica
Niels Fristrup
Torben F Ørntoft
P304
P356
10.1016/J.AJPATH.2012.01.023
P407
P577
2012-03-24T00:00:00Z